• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Lyn Fitzgerald Discusses How NCCN Defines and Assesses Value in Cancer Care

Video

In 2015, NCCN introduced the NCCN evidence blocks which is a tool that allowed for clinicians and patients to have a conversation about what is important to a patient’s individual value system, said Lyn Fitzgerald, senior vice president of US & Global Development at NCCN.

Transcript:

How is NCCN working to define and assess “value” in cancer care?

So, the panel today I talked about the NCCN categories of preference. So, in 2015, NCCN introduced the NCCN evidence blocks which is a tool that allowed for clinicians and patients to have a conversation about what is important to a patient’s individual value system. We’d consider the efficacy of a therapy, safety, quality of the evidence, consistency of the evidence, and affordability.

The categories of preference are another step, it’s another tool to help clinicians with understanding what is optimal care. We believe that value truly is defined by an individual patient’s need and so the categories of preference allow for our panel members to signal to clinicians of all the recommendations in the NCCN guidelines, which are the preferred.

Related Videos
Mansi Shah, MD
Dr John Mascarenhas
CK Wang, MD, COTA
Dr Pankit Vachhani
Screenshot of Ivo Abraham, PhD, RN, during a video interview
Merrill H. Stewart, MD
Dr John Mascarenhas
Carla Nester, MD, MSA, FASN, Stead Family Children's Hospital
Dr John Mascarenhas
Dr Xavier Leleu
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.